Procter & Gamble Hygiene and Health Care Q4 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹22,239 Cr
- P/E
- 28.12
- ROE
- 114.58%
- PEG
- 2.02
- Price to sales
- 5.22
- Debt to equity
- 0.00
- 52W high / low
- ₹13,413 / ₹6,639
- Sales growth (5Y)
- 7.40%
- EBITDA margin
- 25.32%
- Net profit margin
- 19.90%
- Promoter holding
- 70.64%
- Sales (last year)
- ₹4,245 Cr
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.
Guidance scorecard · Q4 FY26 call
What Procter & Gamble Hygiene and Health Care Ltd's management guided
and where it ranks in Personal Products
RevenueQ4 FY26 call
0–10%- The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development.
- Feminine hygiene category is projected to grow at a healthy mid to high single-digit rate.
- Healthcare sub-categories are growing at about 2-3%, with some recent volatility due to seasonal factors like monsoons.
- Focus on evolving sub-segments within categories, e.g., night-time feminine hygiene products and period panties, to drive growth.
- Strategy emphasizes continuous investment in superior products, effective marketing, and enhanced go-to-market capabilities to win consumer preference.
- Despite recent flat sales, profit growth and margin expansion reflect productivity savings fueling reinvestment.
2 more points from Procter & Gamble Hygiene and Health Care Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ4 FY26 call
FlatSee what Procter & Gamble Hygiene and Health Care Ltd said on margins — free account, 30 seconds.
CapexQ4 FY26 call
- When asked about key areas of investment by the Parent company and future investment outlook, the company refrained from providing any details.
- Similarly, questions on manufacturing footprint expansion and buyback of shares were not answered.
- The company explicitly stated they will withhold sharing unpublished price sensitive or confidential information to protect competitive advantage.
FundraisingQ4 FY26 call
See what Procter & Gamble Hygiene and Health Care Ltd said on fundraising — free account, 30 seconds.
Order bookQ4 FY26 call
Ask what Procter & Gamble Hygiene and Health Care Ltd said on the order book →
Full Q4 FY26 analysisRanges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- Strong growth1
- Honasa Consumer LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Personal Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹2,041 Cr | 61.0 | |
| 2 | 40%+ | Flat | ₹400 Cr | 35.6 | |
| 3 | Honasa Consumer Ltd | 20–40% | Up 0–2% | ₹14,745 Cr | 58.4 |
| 4 | 10–20% | Flat | ₹87,493 Cr | 42.1 | |
| 5 | 10–20% | Flat | ₹68,298 Cr | 34.4 | |
| 6 | 10–20% | Flat | ₹16,419 Cr | 21.7 |
Sign up free to see every company in the sector ranking and track Procter & Gamble Hygiene and Health Care Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Personal Products rankingFinancials of Procter & Gamble Hygiene and Health Care Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Procter & Gamble Hygiene and Health Care Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 883 | 853 | 1,138 | 1,133 | 1,002 | 932 | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 |
| Expenses + | 734 | 638 | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 | 723 |
| Operating Profit | 149 | 215 | 285 | 310 | 257 | 118 | 290 | 371 | 210 | 266 | 285 | 402 | 218 |
| OPM % | 17% | 25% | 25% | 27% | 26% | 13% | 26% | 30% | 21% | 28% | 25% | 32% | 23% |
| Other Income + | 14 | 10 | 16 | 16 | 14 | 7 | 8 | 10 | 19 | 8 | 10 | 12 | 12 |
| Interest | 4 | 3 | 2 | 3 | 22 | -0 | 2 | 7 | 6 | 0 | 4 | 3 | 3 |
| Depreciation | 15 | 15 | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 | 10 |
| Profit before tax | 146 | 207 | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 | 218 |
| Tax % | -13% | 27% | 26% | 26% | 34% | 28% | 26% | 26% | 27% | 27% | 26% | 25% | 30% |
| Net Profit + | 165 | 151 | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 | 153 |
| EPS in Rs | 50.84 | 46.59 | 64.91 | 70.52 | 47.56 | 24.97 | 65.28 | 82.74 | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 |
Financials of Procter & Gamble Hygiene and Health Care Ltd
Profit & Loss
Annual income statement trend
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 9m | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 2,334 | 2,275 | 2,320 | 2,455 | 2,947 | 3,002 | 3,574 | 3,901 | 3,918 | 4,206 | 3,374 | 4,290 |
| Expenses + | 1,838 | 1,667 | 1,646 | 1,834 | 2,329 | 2,396 | 2,688 | 3,069 | 3,048 | 3,230 | 2,503 | 3,119 |
| Operating Profit | 495 | 608 | 675 | 622 | 618 | 606 | 886 | 832 | 869 | 976 | 871 | 1,171 |
| OPM % | 21% | 27% | 29% | 25% | 21% | 20% | 25% | 21% | 22% | 23% | 26% | 27% |
| Other Income + | 64 | 85 | 67 | 18 | 45 | 42 | 38 | 23 | 40 | 47 | 37 | 42 |
| Interest | 6 | 6 | 10 | 5 | 5 | 6 | 6 | 11 | 11 | 27 | 14 | 9 |
| Depreciation | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 56 | 32 | 37 |
| Profit before tax | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 839 | 939 | 862 | 1,167 |
| Tax % | 31% | 34% | 36% | 36% | 31% | 27% | 25% | 27% | 19% | 28% | 26% | 27% |
| Net Profit + | 346 | 422 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 856 |
| EPS in Rs | 106.63 | 130.16 | 133.31 | 115.40 | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 196.11 | 263.86 |
| Dividend Payout % | 28% | 28% | 292% | 35% | 68% | 79% | 157% | 90% | 89% | 123% | 89% | 0% |
Financials of Procter & Gamble Hygiene and Health Care Ltd
Balance Sheet
Capital structure and asset base
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 | 721 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 4 | 3 | 2 | 1 |
| Other Liabilities + | 719 | 515 | 634 | 620 | 708 | 671 | 915 | 940 | 1,187 | 1,081 | 1,015 | 1,049 |
| Total Liabilities | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
| Fixed Assets + | 309 | 317 | 286 | 250 | 234 | 206 | 184 | 164 | 170 | 139 | 131 | 163 |
| CWIP | 39 | 35 | 41 | 21 | 15 | 22 | 38 | 44 | 23 | 28 | 41 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 | 1,619 |
| Total Assets | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
Financials of Procter & Gamble Hygiene and Health Care Ltd
Cash Flows
Operating, investing and financing cash movement
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 426 | 352 | 445 | 415 | 413 | 474 | 863 | 573 | 826 | 470 | 593 | |
| Cash from Investing Activity + | 28 | 221 | 149 | -19 | 34 | 75 | 7 | -27 | -10 | 1 | -34 | |
| Cash from Financing Activity + | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -666 | |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 | |
| Free Cash Flow | 348 | 300 | 401 | 377 | 410 | 423 | 832 | 523 | 781 | 427 | 539 | |
| CFO/OP | 127% | 91% | 103% | 111% | 105% | 102% | 126% | 99% | 121% | 79% | 96% |
Financials of Procter & Gamble Hygiene and Health Care Ltd
Ratios
Working capital efficiency and return ratios
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 24 | 21 | 22 | 22 | 20 | 15 | 18 | 20 | 21 | 33 | 21 |
| Inventory Days | 47 | 53 | 71 | 48 | 60 | 68 | 78 | 55 | 48 | 51 | 64 | 51 |
| Days Payable | 148 | 134 | 145 | 156 | 162 | 175 | 237 | 183 | 213 | 193 | 235 | 197 |
| Cash Conversion Cycle | -83 | -57 | -53 | -87 | -79 | -87 | -144 | -110 | -145 | -121 | -138 | -126 |
| Working Capital Days | 4 | 8 | -15 | -23 | -12 | -21 | -39 | -34 | -53 | -32 | -31 | -31 |
| ROCE % | 46% | 45% | 64% | 89% | 73% | 58% | 94% | 110% | 101% | 112% | 104% | 157% |
Guidance history
How Procter & Gamble Hygiene and Health Care Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q4 FY26 call → | 0–10% | Flat | — | — | — |
| Q4 FY25 call → | 0–10% | Up 0–2% | — | — | — |
| Q1 FY25 call → | 0–10% | Flat | — | — | — |
| Q1 FY24 call → | 10–20% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
5 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −48.9% | 5% |
| Last 6 months | −32.5% | 7% |
| Last 3 months | −20.3% | 21% |
The price is 62.7% below its all-time high of ₹18,391.5 (17 Nov 2023). Stocks more than 20% below their peak have their score halved, so 9 became 5.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Procter & Gamble Hygiene and Health Care Ltd: 0.4 × 5 + 0.4 × 7 + 0.2 × 21 = 9, halved to 5 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Procter & Gamble Hygiene and Health Care Ltd's management said in earlier quarters
Others in Personal Products this season
- Aakaar Medical (Q2 FY27)
Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M
- Recode Studios Ltd (Q4 FY26)
The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…
- Godrej Consumer Products Ltd (Q2 FY27)
Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej
- Colgate-Palmolive (India) Ltd (Q2 FY27)
1,692 crore, up 12.2% year-on-year from Rs. Key results statement takeaways from Colgate-Palmolive (India) Ltd's Q2 FY27 results statement — and how it ranks ag